Thalamic metabolism and symptom onset in preclinical Huntington's disease.
about
Four decades of neurodegenerative disease research: how far we have come!Current status of PET imaging in Huntington's diseaseTreatment of Huntington's disease.Functional neuroimaging in Parkinson's diseaseThe development, past achievements, and future directions of brain PETEnhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila modelMolecular Imaging Markers to Track Huntington’s Disease PathologyPhonatory dysfunction as a preclinical symptom of Huntington disease.Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases.Identification of disease-related spatial covariance patterns using neuroimaging dataNeuroimaging in Huntington's disease.Molecular Imaging of Huntington's Disease.Functional imaging in Huntington's disease.Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.Neural correlates of impaired emotion processing in manifest Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Magnetization transfer imaging in 'premanifest' Huntington's diseaseScaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.Functional neuroimaging and chorea: a systematic review.Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 miceStriatal and white matter predictors of estimated diagnosis for Huntington diseaseFDG PET in the Evaluation of Parkinson's Disease.Microcirculation response to local cooling in patients with Huntington's disease.Functional brain networks and abnormal connectivity in the movement disorders.Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions.Abnormal regional brain function in Parkinson's disease: truth or fiction?Impaired sequence learning in dystonia mutation carriers: a genotypic effect.Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.Functional brain networks in movement disorders: recent advancesDifferential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.A disease-specific metabolic brain network associated with corticobasal degeneration.Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's diseaseStriatal volume contributes to the prediction of onset of Huntington disease in incident cases.Metabolic brain networks in translational neurology: concepts and applications.Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.Monitoring Huntington's disease progression through preclinical and early stagesMetabolic network as a progression biomarker of premanifest Huntington's disease.Functional compensation of motor function in pre-symptomatic Huntington's disease.
P2860
Q24645662-4A4CD746-CFCC-4D58-BDA8-FFDD73F99FD5Q26768644-D5A36B13-C661-48C4-8621-81AA3C10EFE4Q26782004-7C843DF5-ED38-453B-AFF4-D0CFF3157063Q27013767-B7839495-2795-4806-A4F7-98DD2ACDF25BQ27026331-2D9C05FD-375B-4EED-B1A4-E28B228A6D45Q28389710-81EAD16F-FA18-4F60-94E4-BF6AD5C8E08AQ29248766-801570C6-1B21-495C-A173-22804DCEEEDCQ30425545-C22B49ED-5810-4E4A-9B82-5A5A7AA32087Q30441887-3B7FEF74-56D6-44C4-8823-AFF4780971ABQ30514157-57822BC5-079A-429E-A7ED-87593E591268Q30655192-C28C0561-1BA5-4806-B109-A0A9FD6E4F09Q30834004-2E3AEE02-9772-4344-B117-6F76CB60CD90Q31139686-7971AD2B-523E-4B3B-8D37-91559F3F106EQ33403110-841FA43A-67F3-412E-A8AA-893D83E9C99FQ33504970-17F975AD-645B-49F0-92EA-516ED5F862CEQ33582389-50AD8AF5-739A-48E2-B18C-21A5B0E457B1Q33606063-7FC6140A-5806-4969-8A8D-A4DBCA3988FBQ33724810-26D72C1A-7D52-43CE-8AC2-6F89AF9E73C1Q33726349-DFD1AB27-D895-4898-8A42-5562435A0890Q33820298-5A0A3E2A-85C5-40D1-9217-28F57961F34CQ33835425-700DFFC2-4688-490E-BCF4-74BE72DA86DDQ33869789-3EB34B29-65F6-4DE3-8693-1FBE5FD4B64FQ33941486-83B1CEA2-55D3-4447-91C2-8FB3F15CFBECQ34035765-47563262-71CE-47E1-9494-6099B446398DQ34052018-24C85811-1CB5-4E8C-AC37-CBC0271445BBQ34114125-790E59BE-F42F-4839-8F5C-04CCE56936F8Q34153434-ACDB164F-5713-472F-B02E-6720FC0DBE8EQ34160477-E7BF06D2-DEEB-4C3E-9504-0D408506EF87Q34180210-B5FCD465-3C07-4C70-A8D5-411DF74F25E8Q34184185-06C3FECB-3052-4FA5-AD77-78F378C182F0Q34308197-14AB6B31-A5A6-4CAA-B33E-96DCBAB8B0B0Q34341619-93E88E8D-541A-4974-8569-F853C29C2536Q34399253-18E12BE6-CE01-4764-9149-423992C28A6EQ35262146-63208F64-4B76-44B1-8DE3-58F57E006266Q35612769-ADAE569A-8E3F-45C0-B0B2-5CED509598D9Q36041821-8408D8ED-271D-41DA-BA19-30CB47F696B5Q36198554-2EED2F5D-5A0E-4F7F-92D0-11D7DA099F2EQ36459201-45FAD76F-AC8F-49DC-A25B-8E256CC80ABDQ37123932-21717B77-4D24-42A6-80AB-55EEB372FBBBQ37201396-A299F9F4-8111-48F5-9502-40E4F1FCC2FD
P2860
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@ast
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@en
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@nl
type
label
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@ast
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@en
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@nl
prefLabel
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@ast
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@en
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@nl
P2093
P2860
P356
P1433
P1476
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
@en
P2093
D Zgaljardic
J S Paulsen
P2860
P304
P356
10.1093/BRAIN/AWM217
P407
P577
2007-09-24T00:00:00Z